Author/Creator: Redell, Mark - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Redell, Mark

1. 1181. Use of the Combination Antibiogram in the Era of MDR Gram-Negative Pathogens. (26th November 2018)

Authors:: Klinker, Kenneth; Cherabuddi, Kartikeya; Redell, Mark; Balogh, Matthew; Massey, Jill; Dudley, Michael
Journal:: Open forum infectious diseases
Issue:: Volume 5(2018)Supplement 1
Page Start:: S357
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. 1928. Comparisons of 30-Day Admission and 30-Day Total Healthcare Costs Between Patients Who Were Treated With Oritavancin (ORI) or Vancomycin (VAN) for a Skin Infection in the Outpatient Setting. (26th November 2018)

Authors:: Lodise, Thomas; Packnett, Elizabeth; Armstrong, Shannon; Redell, Mark
Journal:: Open forum infectious diseases
Issue:: Volume 5(2018)Supplement 1
Page Start:: S555
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. 338Prevalence, Mortality and Outcomes of Antibiotic Therapy of Multi-Drug Resistant Acinetobacter baumannii. (December 2014)

Authors:: Lapensee, Kenneth T.; Fan, Weihong; Redell, Mark; Dudley, Michael; Loutit, Jeff
Journal:: Open forum infectious diseases
Issue:: Volume 1(2014)Supplement 1
Page Start:: S136
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. A Real-world Patient Registry for Oritavancin Demonstrates Efficacy and Safety Consistent With the Phase 3 SOLO Program. (19th March 2018)

Authors:: Redell, Mark; Moeck, Greg; Lucasti, Christopher; Durso, Stephanie; Kennedy, Cynthia; Fusaro, Karen; Loutit, Jeff; Dudley, Michael
Journal:: Open forum infectious diseases
Issue:: Volume 5:Number 6(2018)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Antimicrobial Management of Respiratory Infections in Severe Acute Respiratory Syndrome Coronavirus 2 Patients: Clinical and Antimicrobial Stewardship Programs Conundrums. (26th October 2020)

Authors:: Goldstein, Ellie J C; Tillotson, Glenn; Redell, Mark
Journal:: Open forum infectious diseases
Issue:: Volume 7:Number 11(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Efficacy and Safety of Oritavancin Relative to Vancomycin for Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in the Outpatient Setting: Results From the SOLO Clinical Trials. (19th January 2017)

Authors:: Lodise, Thomas P.; Redell, Mark; Armstrong, Shannon O.; Sulham, Katherine A.; Corey, G. Ralph
Journal:: Open forum infectious diseases
Issue:: Volume 4:Number 1(2017)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Kimyrsa, An Oritavancin-Containing Product: Clinical Study and Review of Properties. (23rd March 2022)

Authors:: Hoover, Randall K; Krsak, Martin; Molina, Kyle C; Shah, Kairav; Redell, Mark
Journal:: Open forum infectious diseases
Issue:: Volume 9:Number 5(2022)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Minocycline Intravenous for the Treatment of Serious Infections Due to Gram-Negative Nonpseudomonal Bacteria, Including Stenotrophomonas maltophilia, Acinetobacter baumannii, and Burkholderia cepacia. Issue 4 (July 2020)

Authors:: Sierra-Hoffman, Miguel; Redell, Mark; Benefield, Russell; Caruso, Patricia; Estrada, Sandy; Leuthner, Kimberly; Zappas, Kristie; Kennedy, Cynthia; Massey, Jill
Journal:: Infectious diseases in clinical practice
Issue:: Volume 28:Issue 4(2020:Jul.)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗